October 13, 2009
Merial expands vaccine production plant in Nanchang, China
Merial, the animal health division of the Sanofi-aventis Group, announced Monday (Oct 12) that Merial Animal Health Co (China) held a ground-breaking ceremony for an expansion project at its plant located in the Nanchang Hi-tech Development Zone, China.
Merial Animal Health Co (China), a venture of Merial Limited and the Group's first production facility in China has been in operation for almost 20 years.
The facility in Nanchang produces poultry vaccines for the domestic Chinese market. With an estimated total investment of over US$70 million, the completion of the expansion project will double the production capacity of the Nanchang plant. The new facility will cover an area of 50,000 square metres, with a phase I floor area of nearly 30,000 square metres.
The expansion project is expected to extend Merial's leadership in China in terms of high-quality vaccine offerings as well as sales, technical support and logistics.
Established in 1997, Merial Limited is now a wholly-owned subsidiary of Sanofi-aventis. Merial is a leading animal health company that provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.
